Shopping Cart
- Remove All
- Your shopping cart is currently empty
Moxaverine hydrochloride is a derivative of papaverine, a phosphodiesterase inhibitor. Moxaverine has been studied in phase III of a clinical trial for the treatment of ocular blood flow in patients with age- related macular degeneration and primary open angle glaucoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 2.441 € | 10-14 weeks | |
50 mg | 3.211 € | 10-14 weeks | |
100 mg | 4.370 € | 10-14 weeks |
Description | Moxaverine hydrochloride is a derivative of papaverine, a phosphodiesterase inhibitor. Moxaverine has been studied in phase III of a clinical trial for the treatment of ocular blood flow in patients with age- related macular degeneration and primary open angle glaucoma. |
Molecular Weight | 343.85 |
Formula | C20H22ClNO2 |
Cas No. | 1163-37-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.